Dev Chatterjee, Raghavendra Kamath, Sohini Das &Amp;Amp; Avishek Rakshit

Stories by Dev Chatterjee, Raghavendra Kamath, Sohini Das &Amp;Amp; Avishek Rakshit

The take-off and crash-landing of Jet's Naresh Goyal

The take-off and crash-landing of Jet's Naresh Goyal

Rediff.com   4 Sep 2023

In a dramatic turn of events in May 2019, an Emirates aircraft en-route to Dubai was asked to stop while it was taxiing for a take off in Mumbai. The pilot was given no reason and ordered to immediately return to the parking bay. As the aircraft returned to the terminal, two passengers from the first class - Naresh Goyal and his wife Anita - were offloaded by the immigration authorities, who said the duo cannot leave the country. Goyal, founder of Jet Airways, was stunned. The man, who ruled the aviation sector for two and a half decades with an iron hand, did not expect to be offloaded in this fashion.

From hatchbacks to holidays, consumers ready to loosen purse strings

From hatchbacks to holidays, consumers ready to loosen purse strings

Rediff.com   1 Sep 2023

With Onam and Raksha Bandhan just around the corner, the festival season is ready to kick off in full swing. As people embrace the celebratory spirit, companies anticipate a surge in sales this year. Consumer durables firms are expecting strong growth of 40-50 per cent in the premium segment during the upcoming season. Appliance makers also foresee increased demand for cooling appliances - refrigerators and air conditioners - which were impacted by unseasonal rainfall.

47,000 Luxury Cars To Be Sold This Year!

47,000 Luxury Cars To Be Sold This Year!

Rediff.com   28 Aug 2023

After a brief lull during the pandemic, there is a strong revival in luxury car sales, bolstered by more launches across price bands, replacement demand, ban on old diesel vehicles in the NCR, and 'revenge buying'.

Why All Is Not Well In Bharat Gears Family

Why All Is Not Well In Bharat Gears Family

Rediff.com   26 Aug 2023

The sons learned that they had been completely disinherited and that Surinder Kanwar's new wife would inherit everything.

The Unholy Rift Between Companies And Auditors

The Unholy Rift Between Companies And Auditors

Rediff.com   25 Aug 2023

38 auditors resigned in 2022-23, compared with 46 the previous year.

Adani shares lose Rs 55K cr in market cap even after record quarterly profit

Adani shares lose Rs 55K cr in market cap even after record quarterly profit

Rediff.com   24 Aug 2023

The combined market capitalisation of Adani Group companies fell by Rs 54,876 crore, to Rs 10.92 trillion, as investor sentiment turned bearish on Wednesday. Shares of Adani Transmission fell by 7.7 per cent to close at Rs 886 while those of Adani Power lost 7.1 per cent to end the day at Rs 323. The stock of Adani Enterprises, the flagship company of the group, lost 6.2 per cent to finish at Rs 2,530.

'Which country is now standing tall in BRICS? It's India'

'Which country is now standing tall in BRICS? It's India'

Rediff.com   23 Aug 2023

'India has the potential to do a lot more to take advantage of the time today where we stand to gain, geopolitically and in terms of market attractiveness.'

'Power shifts to chemists instead of doctors'

'Power shifts to chemists instead of doctors'

Rediff.com   22 Aug 2023

'Whichever company offers better incentives, the chemist would prefer it.'

Tata Sons chairman Chandrasekaran earns Rs 113 cr as FY23 remuneration

Tata Sons chairman Chandrasekaran earns Rs 113 cr as FY23 remuneration

Rediff.com   10 Aug 2023

Tata Sons chairman Natarajan Chandrasekaran was paid Rs. 113 crore as remuneration for 2022-23 (FY23), including Rs. 100 crore as commission on profit. Chandrasekaran, 60, often referred to as Chandra, received a remuneration of Rs. 109 crore in 2021-22 (FY22). With this, Chandra has emerged as one of the highest-paid chief executive officers (CEO) in Corporate India for FY23.

Why Dolo, Saridon, Calpol Will Have QR Codes

Why Dolo, Saridon, Calpol Will Have QR Codes

Rediff.com   8 Aug 2023

The top 300 pharmaceutical brands in the country will now bear a quick response (QR) code on their packaging to rein in spurious drugs and ensure better traceability.

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Big pharma firms shift tack, look to bet on trade generics as volumes dip

Rediff.com   7 Aug 2023

Trade generic drugs (medicines that are sold directly through distributors) are fast becoming a key segment for domestic pharma firms as volume growth slows in the overall market. Big companies like Cipla and Alkem have a significant presence in the segment but recently, players like Torrent Pharmaceuticals and Dr Reddy's Laboratories (DRL) have also entered this market. What is driving big pharma's focus on trade generics? The volume growth in the Indian Pharma Market (IPM) has come down from 5.6 per cent in FY16 to 0.1 per cent in FY23.

M&M picks 3.5% stake in RBL Bank for Rs 417 cr, eyes to acquire more

M&M picks 3.5% stake in RBL Bank for Rs 417 cr, eyes to acquire more

Rediff.com   27 Jul 2023

Diversified business conglomerate Mahindra and Mahindra (M&M) has picked up a 3.53 per cent stake in private sector lender RBL Bank for Rs. 417 crore. "We may consider further investment, subject to pricing, regulatory approvals, and required procedures. However, in no circumstance will it exceed 9.9 per cent," M&M said in an exchange notification on Wednesday. Shares of RBL Bank jumped 7.1 per cent to settle at Rs. 238.8 apiece on the BSE on Wednesday, close to their 52-week high of Rs. 242.1.

Tata Motors applies for PLI benefits for Tiago electric car

Tata Motors applies for PLI benefits for Tiago electric car

Rediff.com   27 Jul 2023

Tata Motors, the market leader in electric four-wheeler space, has sought incentives for its Tiago EV under the government's production-linked incentive (PLI) scheme, group chief financial officer P B Balaji said on Tuesday. The Mumbai-headquartered firm has applied for all variants of the Tiago, which recently hit a sales milestone of 10,000 units. "The Automotive Research Association of India certification is done.

Bain to buy 90% stake in Adani Capital and Adani Housing for Rs 1,600 cr

Bain to buy 90% stake in Adani Capital and Adani Housing for Rs 1,600 cr

Rediff.com   24 Jul 2023

The Adani group has exited the financial services business by selling its entire 90 per cent stake in Adani Capital and Adani Housing to private equity (PE) firm Bain Capital for Rs 1,440 crore. The total valuation of the Adani financial services business stands at Rs 1,600 crore. Gaurav Gupta, managing director (MD) and chief executive officer (CEO) of the Adani firms will hold the rest of the stake.

US drug shortage, stable pricing set to boost pharma revenues

US drug shortage, stable pricing set to boost pharma revenues

Rediff.com   24 Jul 2023

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India's pharmaceutical companies during the first quarter of this financial year, analysts said. Most brokerages estimate a top line growth of around 14-15 per cent, with earnings before interest, taxes, depreciation, and amortisation (Ebitda) growth of 24-30 per cent for Q1 of FY24. Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon.

Price hikes, lower input costs to aid auto firms' Q1

Price hikes, lower input costs to aid auto firms' Q1

Rediff.com   22 Jul 2023

Auto industry volumes have grown by 2.5 per cent overall, led by domestic sales of three-wheelers, two-wheelers and passenger vehicles (PVs) in the first quarter of this financial year. Analysts predict an 18 per cent growth in revenues for automotive original equipment manufacturers (OEMs) and profit growth of 69 per cent year-on-year (YoY). However, on a sequential basis, a decline in revenues as well as earnings before interest, taxes, depreciation, and amortisation (Ebitda) margins is expected.

What is Schedule M and why it's mandatory for all pharma units

What is Schedule M and why it's mandatory for all pharma units

Rediff.com   12 Jul 2023

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will be made compulsory for small and medium scale manufacturers in a phased manner. Union Health Minister Mansukh Mandaviya has asked micro-small and medium enterprises in pharma manufacturing to move towards good manufacturing practices (GMP) through self regulation. "This will help in quality assurance and also reduce compliance burden," Mandaviya.

As demand for EV batteries picks up, makers eye lithium reserves

As demand for EV batteries picks up, makers eye lithium reserves

Rediff.com   3 Jul 2023

The EV industry is at an inflection point and batteries will play a critical role ahead -- batteries and related components typically constitute 35-45 per cent of an EV's costs.

'Mercedes To Launch 10 Cars In 2023'

'Mercedes To Launch 10 Cars In 2023'

Rediff.com   3 Jul 2023

'And a majority will be in the top-end vehicle range.'

By 2025 Indian Trucks Will Have AC Cabin

By 2025 Indian Trucks Will Have AC Cabin

Rediff.com   3 Jul 2023

'Instead of ACs, the government should do something to increase our salary.'